ORIGINAL STUDIES |
|
Ponezheva Z.B., Grishaeva А.А., Alimova L.K., Burdakova E.A., Makashova V.V., Krasnova S.V.
Clinical and laboratory characteristics of severe forms of new coronavirus infection
|
7-13 |
Amon E.P., Esaulenko E.V., Taganov A.V., Shiryaeva M.A., Malinnikova E.Yu.
Therapy of acute respiratory viral infections in outpatient practice during the COVID-19 pandemic
|
14-26 |
Veselova E.I., Karamov E.V., Kudlay D.A., Samoilova A.G., Kaminsky G.D.
Efficacy and safety of antiretroviral therapy in «naive» patients with late stage of HIV infection
|
27-34 |
Kapustin D.V., Krasnova E.I., Khalikov M.R., Pozdnyakova L.L., Khokhlova N.I., Maksimenko L.V., Ekushov V.E., Totmenin A.V., Gashnikova N.M.
Analysis of the prevalence of HIV-1 primary resistance to antiretroviral medicinal agents in Novosibirsk region
|
35-41 |
Danilov A.N., Sotskova V.A., Shuldyakov A.A., Lyapina E.P., Kolokolov O.V.
HIV-infection and sexually transmitted infections: regional trends
|
42-49 |
Esaulenko E.V., Dzemova A.A., Novak K.E., Bushmanova A.D., Ostankova Yu.V., Valutite D.E., Chernoguz Yu.A., Zueva E.B., Yushina E.Yu., Tyurenkova N.V.
Analysis of long-term results of effective etiotropic therapy of chronic hepatitis C
|
50-58 |
Kichatova V.S., Kyuregyan K.K., Carlsen A.A., Potemkin I.A., Asadi Mobarkhan F.A., Isaeva O.V., Lopatukhina M.A., Malinnikova E.Yu., Kravchenko I.E., Znoyko O.O., Yuschuk N.D., Mikhailov M.I.
Frequency of detecting markers of hepatitis C among the conditionally healthy population of Tatarstan Republic
|
59-66 |
Derevyanchenko M.V., Fedotov V.V., Shaposhnikova M.Yu., Kolodin S.V.
Assessment of the risk of developing cardiovascular diseases on the SCORE-2 and SCORE 2-OP scale in patients with arterial hypertension using software tools
|
67-71 |
REVIEWS |
|
Stepanova E.V., Loranskaya I.D., Osadchuk A.M.
Eating disorders: problems of a gastroenterologist
|
72-80 |
Oleynikov V.E., Donetskaya N.A., Vdovkin A.V., Avdeeva I.V., Sretenskaya E.A., Borisova N.A.
Diagnosis of non-ischemic myocardial injury in acute COVID-19 cardiovascular syndrome
|
81-90 |
Alieva A.M., Reznik E.V., Teplova N.V., Batov M.A., Shnahova L.M., Arakelyan R.A., Baykova I.E., Totolyan G.G., Volynkina V.M., Kislyakov V.A., Nikitin I.G.
Prognostic value of cardiac troponins in case of COVID-19
|
91-100 |
Adasheva T.V., Samorukova E.I., Gubernatorova E.E., Lobanova E.G., Goruleva E.I.
Long-term COVID-19 syndrome and endotheliopathy: pathophysiological mechanisms and therapeutic strategies
|
101-108 |
GUIDELINES FOR PRACTITIONERS |
|
Ilchenko L.Yu., Asadi Mobarkhan F.A., Karlsen A.A., Potemkin I.A., Malinnikova E.Yu., Kyuregyan K.K., Mikhailov M.I.
Chronic hepatitis E in a patient with Burkitt’s lymphoma
|
109-115 |
Poteshkina N.G., Kovalevskaya E.A., Shashkina Ya.R., Vdovenko I.A., Fetzer D.V., Karasev A.A., Krylova N.S.
Acute coronary syndrome in patients with COVID-19-associated pneumonia
|
116-125 |
Budko A.A., Georginova O.A.
Reactivation of cytomegalovirus infection in a rheumatoid arthritis patient with immunosuppressive therapy in the background
|
126-129 |
Guideline for practitioners |
|
Possibilities of modern drug therapy for novel coronavirus infection in outpatient conditions (Resolution of the Expert council)
|
130-133 |
LECTURE |
|
Bolieva L.Z., Malyavin A.G., Aidarova N.K., Byazrova S.S.
Multisystem inflammatory syndrome in adults associated with COVID-19
|
134-143 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
|
Kamchatnov P.R., Khanmurzayeva S.B., Chugunov A.V., Khanmurzayeva N.B.
Neurological aspects of the postcovide syndrome
|
144-152 |
Activities of RNMOT |
|
«Zavadsky readings»-2022: results
|
153-154 |
Interregional research and practical conferences, round tables and educational seminars of RSMSIM (March – April 2022)
|
155-158 |